Genetic causes of Raynaud’s phenomenon identified

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for people with Raynaud’s.

J&J builds out global manufacturing capacity for CAR-T Carvykti

Johnson & Johnson is ramping up manufacturing capacity for the CAR-T therapy it developed with Legend Biotech, driven by high demand for the Carvykti, executives

October 20, 2023

Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer – Biotech Investments

Lonza Group AG / Key word(s): Expansion Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer 13.10.2023 / 08:00 CET/CEST

October 14, 2023

Prescription for resilience: Health care needs financial sector-inspired regulation

In the early days after it was hit by a cyberattack on Feb. 21, Change Healthcare, one of the country’s largest claims and prescription processors,

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.